Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 02:23PM ET
5.14
Dollar change
+0.02
Percentage change
0.29
%
IndexRUT P/E- EPS (ttm)-1.45 Insider Own12.10% Shs Outstand88.45M Perf Week-2.19%
Market Cap463.74M Forward P/E- EPS next Y-2.06 Insider Trans0.00% Shs Float79.39M Perf Month-36.13%
Income-102.07M PEG- EPS next Q-0.40 Inst Own77.97% Short Float12.69% Perf Quarter-13.11%
Sales34.48M P/S13.45 EPS this Y-26.40% Inst Trans8.98% Short Ratio6.13 Perf Half Y9.49%
Book/sh4.17 P/B1.23 EPS next Y-17.81% ROA-24.74% Short Interest10.07M Perf Year8.56%
Cash/sh3.64 P/C1.41 EPS next 5Y14.50% ROE-30.50% 52W Range3.44 - 8.59 Perf YTD-10.38%
Dividend Est.- P/FCF- EPS past 5Y-37.16% ROI-25.89% 52W High-40.22% Beta2.48
Dividend TTM- Quick Ratio11.97 Sales past 5Y71.11% Gross Margin81.70% 52W Low49.27% ATR (14)0.43
Dividend Ex-Date- Current Ratio11.97 EPS Y/Y TTM11.39% Oper. Margin-336.63% RSI (14)35.60 Volatility6.54% 8.22%
Employees158 Debt/Eq0.07 Sales Y/Y TTM148.91% Profit Margin-296.05% Recom1.25 Target Price18.57
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q11.80% Payout- Rel Volume0.58 Prev Close5.12
Sales Surprise-10.02% EPS Surprise-6.12% Sales Q/Q-3.63% EarningsMar 11 AMC Avg Volume1.64M Price5.14
SMA20-16.76% SMA50-18.96% SMA200-9.42% Trades Volume730,009 Change0.29%
Date Action Analyst Rating Change Price Target Change
Nov-08-23Initiated Cantor Fitzgerald Neutral
Oct-31-23Initiated Evercore ISI Outperform $13
Jul-11-23Initiated Truist Buy $23
Feb-18-22Initiated RBC Capital Mkts Outperform $22
Dec-01-21Initiated Oppenheimer Outperform $36
Nov-30-21Initiated H.C. Wainwright Buy $28
Nov-15-21Upgrade Citigroup Neutral → Buy $27
Aug-17-21Initiated SVB Leerink Outperform $32
Aug-17-21Initiated Citigroup Neutral $27
Aug-17-21Initiated BofA Securities Buy $30
Mar-14-24 12:00PM
Mar-13-24 03:32PM
Mar-12-24 12:37PM
Mar-11-24 04:05PM
Mar-05-24 04:30PM
01:14PM Loading…
Feb-26-24 01:14PM
06:45AM
Feb-23-24 11:25PM
Feb-15-24 04:05PM
Feb-12-24 08:30AM
Jan-15-24 08:45AM
Jan-07-24 11:00AM
Dec-13-23 07:26AM
05:20AM
Dec-12-23 04:02PM
12:00PM Loading…
Dec-08-23 12:00PM
Dec-06-23 09:55AM
Nov-20-23 09:55AM
Nov-07-23 04:00PM
Nov-06-23 08:00AM
Nov-01-23 04:05PM
Oct-20-23 05:00AM
Oct-18-23 08:00AM
Oct-11-23 06:00AM
Oct-10-23 05:40AM
Oct-05-23 10:07AM
Sep-27-23 08:30AM
08:00AM
Sep-23-23 08:45AM
Aug-29-23 04:00PM
05:58AM Loading…
Aug-24-23 05:58AM
Aug-15-23 04:08PM
03:08PM
Aug-08-23 05:15PM
04:00PM
Jul-28-23 08:30AM
Jul-22-23 09:45AM
Jul-21-23 10:00AM
Jul-20-23 11:35AM
Jul-19-23 09:30AM
Jul-17-23 05:03PM
Jul-14-23 11:27AM
Jul-13-23 11:15PM
04:03PM
04:01PM
04:01PM
09:30AM
Jul-12-23 09:40AM
Jul-11-23 09:55AM
Jul-07-23 08:14AM
Jul-06-23 11:03PM
01:56PM
11:54AM
10:43AM
08:00AM
Jun-15-23 12:53PM
May-31-23 04:00PM
May-16-23 11:25AM
May-09-23 05:15PM
04:00PM
May-08-23 09:00AM
May-01-23 04:00PM
Apr-26-23 02:10PM
Apr-17-23 01:30PM
Apr-04-23 08:00AM
Mar-29-23 08:00AM
08:00AM
Mar-11-23 07:31AM
Mar-09-23 07:25PM
05:09PM
Mar-08-23 04:05PM
Mar-07-23 12:10PM
Feb-01-23 04:05PM
Jan-06-23 11:01AM
Jan-03-23 04:05PM
Dec-12-22 08:01AM
08:00AM
Dec-07-22 09:52AM
Nov-29-22 09:00AM
Nov-21-22 09:00AM
Nov-09-22 07:57AM
Nov-08-22 05:15PM
04:00PM
Nov-07-22 04:05PM
Nov-03-22 09:00AM
Oct-18-22 09:00AM
Oct-14-22 09:49AM
Sep-28-22 12:33PM
Sep-03-22 08:03AM
Aug-31-22 04:05PM
Aug-18-22 02:14PM
Aug-09-22 05:25PM
04:00PM
Jul-30-22 09:50AM
Jul-28-22 08:30AM
Jun-30-22 07:29AM
Jun-13-22 02:41PM
02:06PM
Jun-10-22 03:00AM
Jun-01-22 04:05PM
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kanner StevenChief Scientific OfficerFeb 06 '24Option Exercise2.6930,57782,252354,037Feb 08 05:06 PM
Haurwitz Rachel E.President and CEOJun 08 '23Option Exercise2.9610,00029,60040,000Jun 09 04:31 PM